Eltrombopag
ʻO Eltrombopag ka inoa maʻamau no ka lāʻau kālepa inoa Promacta. I kekahi mau hihia, hiki i nā limahana mālama ola ke hoʻohana i ka inoa kālepa, Promacta, i ka wā e pili ana i ka inoa lāʻau maʻamau, eltrombopag.
Hoʻohana ʻia kēia lāʻau lapaʻau no ka mālama ʻana i nā pae platelet haʻahaʻa i nā poʻe i loaʻa i kekahi maʻi koko i kapa ʻia ʻo chronic immune (idiopathic) thrombocytopenia purpura (ITP) a i ʻole he maʻi hepatitis C mau loa. anemia).
Hoʻohana ʻia ʻo Eltrombopag no ka pale ʻana i ke kahe koko i nā pākeke a me nā keiki i piha i ka makahiki 1 a keu, i loaʻa i ka maʻi maʻi.immune thrombocytopenic purpura(ITP). He maʻi koko ka ITP ma muli o ka nele o nā platelets i loko o ke koko.
ʻAʻole ʻo Eltrombopag kahi lāʻau lapaʻau no ITP a ʻaʻole ia e hoʻolilo i kāu platelet helu maʻamau inā loaʻa iā ʻoe kēia maʻi.
Hoʻohana pū ʻia ʻo Eltrombopag no ka pale ʻana i ke koko i nā pākeke me ka maʻi hepatitis C mau loa i mālama ʻia me kahi interferon (e like me Intron A, Infergen, Pegasys, PegIntron, Rebetron, Redipen, a i ʻole Sylatron).
Hoʻohana pū ʻia ʻo Eltrombopag me nā lāʻau lapaʻau ʻē aʻe e mālama i ka maʻi koʻikoʻianemia aplastici nā mākua a me nā keiki ma lalo o 2 mau makahiki.
Hāʻawi ʻia ʻo Eltrombopag i kekahi manawa ma hope o ka pau ʻole o nā lāʻau lapaʻau ʻē aʻe.
ʻAʻole hoʻohana ʻia ʻo Eltrombopag i ka mālama ʻana i ka myelodysplastic syndrome (i kapa ʻia ʻo "preleukemia").
Hiki ke hoʻohana ʻia ʻo Eltrombopag no nā kumu i helu ʻole ʻia ma kēia alakaʻi lāʻau lapaʻau.
Manaʻo18Nā papahana Loiloi Kūlike Kūlike i ʻae ʻia4, a6apono ʻia nā papahana.
Ua hoʻokumu ka ʻōnaehana hoʻokele maikaʻi honua kiʻekiʻe i ke kumu kūʻai.
Holo ka nānā ʻana i ka maikaʻi ma ke ola holoʻokoʻa o ka huahana e hōʻoia i ka maikaʻi a me ka hopena therapeutic.
Kākoʻo ka hui ʻoihana Regulatory Affairs i nā koi maikaʻi i ka wā o ke noi a me ke kākau inoa ʻana.